Hymenoptera Anaphylaxis as a Clonal Mast Cell Disorder

Immunol Allergy Clin North Am. 2018 Aug;38(3):455-468. doi: 10.1016/j.iac.2018.04.010. Epub 2018 Jun 9.

Abstract

Up to 7% of adult patients with Hymenoptera venom allergy may suffer from a clonal mast cell disease. Patients with clonal mast cell disease and Hymenoptera venom anaphylaxis are commonly males, without skin lesions, and anaphylaxis is characterized by hypotension and syncope in the absence of urticaria and angioedema. A normal value of tryptase does not exclude a mastocytosis. The diagnosis of a mast cell disease leads to several therapeutic consequences concerning the treatment of Hymenoptera venom allergy as matter of fact these patients have to undergo long-life venom immunotherapy, to prevent further, potentially fatal severe reactions.

Keywords: Anaphylaxis; Clonal mast cell disease; Hymenoptera venom allergy; Monoclonal mast cell activation syndrome; Systemic mastocytosis; Tryptase.

Publication types

  • Review

MeSH terms

  • Allergens / immunology
  • Allergens / therapeutic use
  • Anaphylaxis / immunology*
  • Anaphylaxis / prevention & control
  • Animals
  • Bee Venoms / immunology
  • Bee Venoms / therapeutic use
  • Desensitization, Immunologic / methods*
  • Humans
  • Hymenoptera / immunology
  • Hypersensitivity / immunology*
  • Hypersensitivity / therapy
  • Hypotension
  • Male
  • Mast Cells / physiology*
  • Mastocytosis / immunology*
  • Sex Factors
  • Syncope
  • Wasp Venoms / immunology
  • Wasp Venoms / therapeutic use

Substances

  • Allergens
  • Bee Venoms
  • Wasp Venoms